why choose us

First received: February 17, 2023

Clinical Trial: Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pancreatic Neuroendocrine Neoplasm

Study Type: OBSERVATIONAL


Official Title: Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

Brief Summary: This is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating locations with a new or existing diagnosis of Pancreatic Neuroendocrine Neoplasms (PanNEN).This protocol is an extension of existing Genetic Testing Station efforts at University of California, San Francisco (UCSF)

Read more